Delving into the Latest Updates on Diphtheria,tetanus and acellular pertussis combined Vaccine,adsorbed(Sanofi Pasteur) with Synapse

Overview

Basic Info

Drug Type

Combination vaccine, Prophylactic vaccine

Synonyms-

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas

Infectious DiseasesRespiratory DiseasesOther Diseases+ [1]

Active Indication-

Inactive Indication

DiphtheriaHaemophilus InfectionsPoliomyelitis+ [2]

Originator Organization

Sanofi Pasteur Ltd.

Active Organization-

Inactive Organization

SanofiSanofi Pasteur Ltd.

License Organization-

Drug Highest PhasePendingNDA/BLA

First Approval Date-

Regulation-

Login to view timeline

As per request by the Heath Authorities, the present clinical study will assess the immunogenicity and safety of sanofi pasteur's DTacP-IPV// PRP
T combined vaccine (PENTAXIM™) as a three-dose primary vaccination at 2, 3, and 4 months of age or 3, 4 and 5 months of age followed by a booster dose at 18-20 months of age as compared to commercially available DTacP, Hib conjugate (Act-HIB™) and IPV (IMOVAX Polio™) monovalent vaccines in order to meet the requirements for registration of the product in People's Republic of China.

Start Date01 Mar 2007

Sponsor / Collaborator

Sanofi

NCT00254969

/ CompletedPhase 3

Immunogenicity and Safety of Pentaxim in South African Infants

The present clinical study will assess the immunogenicity and reactogenicity of Aventis Pasteur's DTacP-IPV// PRP
T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vaccination at 6, 10 and 14 weeks of age followed by a booster dose during the second year of life in order to meet the requirements for application for the use of the product in the Expanded Program on Immunization (EPI) in South Africa.

Start Date01 Oct 2005

Sponsor / Collaborator

Sanofi

100 Clinical Results associated with Diphtheria,tetanus and acellular pertussis combined Vaccine,adsorbed(Sanofi Pasteur)

Login to view more data

100 Translational Medicine associated with Diphtheria,tetanus and acellular pertussis combined Vaccine,adsorbed(Sanofi Pasteur)

Login to view more data

100 Patents (Medical) associated with Diphtheria,tetanus and acellular pertussis combined Vaccine,adsorbed(Sanofi Pasteur)

Login to view more data

100 Deals associated with Diphtheria,tetanus and acellular pertussis combined Vaccine,adsorbed(Sanofi Pasteur)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Diphtheria	NDA/BLA	China	Sanofi Pasteur Ltd.	13 Nov 2015
Tetanus	NDA/BLA	China	Sanofi Pasteur Ltd.	13 Nov 2015
Whooping Cough	NDA/BLA	China	Sanofi Pasteur Ltd.	13 Nov 2015
Haemophilus Infections	Phase 3	South Africa	Sanofi	01 Oct 2005
Poliomyelitis	Phase 3	South Africa	Sanofi	01 Oct 2005